- US12129496utility2024Haplotype-based Treatment of RP1 Associated Retinal Degenerations0 cites
- US12121608utility2024Biodegradable Implant for Sustained Trans-nasal Delivery of Therapeutic Agents to the Brain0 cites
- US12121630utility2024Light Activated Adhesive Scaffold0 cites
- US11963905utility2024Methods of Delivering an Agent to the Eye0 cites
- US11963968utility2024Treatment of Hearing Loss0 cites
- US11844571utility2023Grading Corneal Fluorescein Staining0 cites
- US11826098utility2023System and Method for the Treatment of Amblyopia0 cites
- US11806524utility2023Bimodal Hybrid Cochlear Implants0 cites
- US11786117utility2023Mobile Device Application for Ocular Misalignment Measurement0 cites
- US11786574utility2023Treatment of Rhinosinusitis with P-glycoprotein Inhibitors0 cites
- US11789024utility2023Biomarkers for Age-related Macular Degeneration0 cites
- US11744817utility2023High-dose Statins for Age-related Macular Degeneration0 cites
- US11607658utility2023Formation of Colloids or Gels Within Droplets0 cites
- US11590152utility2023Treatment of Hearing Loss0 cites
- US11564625utility2023Tissue Force Sensor Systems and Methods of Use0 cites
- US11547779utility2023Methods and Polymer Compositions for Treating Retinal Detachment and Other Ocular Disorders0 cites
- US11541072utility2023Aav-crispr/cas9 Genome Editing of VEGFR2 for Treating Ocular Diseases0 cites
← PreviousPage 2 of 2